- Home
- Equipment
- usa massachusetts
- genetic disease
Show results for
Refine by
Genetic Disease Equipment Supplied In Usa Massachusetts
5 equipment items found
by:Neoclease based inBoston, MASSACHUSETTS (USA)
These enzymes are meticulously crafted using proprietary algorithms powered by state-of-the-art GPT neural networks, which are capable of redesigning nucleases for specific genetic targets. This approach allows Neoclease to tailor solutions uniquely to each client's needs. The focus on innovation extends to the creation of comprehensive nuclease libraries, ensuring a wide range ...
by:Vertex Pharmaceuticals based inBoston, MASSACHUSETTS (USA)
Cystic fibrosis (CF) is a rare, chronic and life-shortening genetic disease. It’s a progressive, multi-system disease that affects the lungs, liver, gastrointestinal tract, pancreas, sinuses, sweat glands and reproductive tract. In the lungs, this leads to the buildup of abnormally thick, sticky mucus that can cause chronic lung infections ...
Manufactured by:Editas Medicine based inCambridge, MASSACHUSETTS (USA)
Genomic medicine is a developing field of medical research that harnesses recent advances in genetics to develop new medicines for diseases. In fact, we are at an inflection point where we are seeing the first real genomic medicines emerge to help patients. Advances in the scientific fields of cell therapy and gene therapy have paved the way for the success of ...
by:Aegle Therapeutics based inWoburn, MASSACHUSETTS (USA)
Aegle’s founder Dr. Evangelos Badiavas and his team have spent decades researching clinical applications of mesenchymal stem cells (“MSCs”) in severe dermatological disorders, including conducting clinical trials in burns and wounds under multiple INDs. In these trials, patients experienced accelerated healing, little to no scarring, total wound closure and tissue regeneration. ...
by:Intellia Therapeutics, Inc. based inCambridge, MASSACHUSETTS (USA)
CRISPR/Cas9 genome editing can make permanent, precisely targeted changes in patients’ chromosomes and repair the underlying genetic mutation, whereas more traditional gene therapy typically involves introducing a non-permanent copy of a gene into patients’ cells. These attributes of CRISPR/Cas9 provide a significant therapeutic edge over other gene therapy and costly ...